Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Domilens is a specialized medical device company focused on the field of ophthalmology, particularly cataract and refractive surgery. Founded in 1984 in Lyon, France, the company established itself as a leader in the European market through the development of innovative intraocular lenses (IOLs) and viscoelastic solutions. In 1998, Domilens was acquired by Bausch + Lomb for approximately $100 million, a move that significantly bolstered Bausch + Lomb's surgical presence in Europe. The company's product portfolio includes a variety of monofocal and multifocal lenses designed to treat aphakia and presbyopia. Today, the Domilens brand continues to operate under the Bausch + Lomb umbrella, maintaining a strong distribution network and reputation for quality in ophthalmic surgical products. Its legacy includes pioneering work in foldable lens technology and surgical instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratories Domilens.